Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Edwards Lifesciences Corp (EW) has a market cap of $45.09B with year-over-year revenue growth of -9.4%. Net margin stands at 76.7%. The stock trades at a P/E ratio of 10.8.
Compared to other companies in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector, EW posted revenue growth of -9.4% and trades at a P/E of 10.8.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.